Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06402773 · ClinicalTrials.gov registry record · NA
A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy
A NA study of Vasectomy, sponsored by Signati Medical.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06402773: Completed NA study of Vasectomy, sponsored by Signati Medical.
NCT06402773 is a NA study of Vasectomy that has completed, run by Signati Medical. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06402773, a NA study of Vasectomy, has completed, sponsored by Signati Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Signati SeparoTM System when used in general surgical procedures where ligation and division of vessels are desired, such as the vas deferens. This study will evaluate the Signati SeparoTM System as a vasectomy device.
Primary Outcome
Incidence, type, duration, severity, and relationship to the study device.
Conditions Studied
Interventions
- DEVICE The Signati Separo™ Vessel Sealing System
Study Locations (1)
Louisiana
- LSU Health - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
What the finished NCT06402773 record still lists
NCT06402773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vasectomy appearing as the primary indexed condition, and to 1 intervention - of which The Signati Separo™ Vessel Sealing System is the first listed.
NCT06402773 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06402773 about?
NCT06402773 is a clinical study titled "A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy". The purpose of this study is to evaluate the safety and effectiveness of the Signati SeparoTM System when used in general surgical procedures where ligation and division of vessels are desired, such as the vas deferens. This study will evaluate the Signati SeparoTM System as a vasectomy device.
What is the current status of trial NCT06402773?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-04-05. Estimated completion is 2024-12-30.
What conditions does trial NCT06402773 study?
This clinical trial studies the following conditions: Vasectomy.
What interventions are being tested in trial NCT06402773?
The interventions under investigation include: The Signati Separo™ Vessel Sealing System (DEVICE).
Who is sponsoring clinical trial NCT06402773?
This trial is sponsored by Signati Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06402773 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06402773's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI